OCEANIC-AF: Differences in Outcomes in Patients With and Without Prior Use of OACs?
Apr 10, 2025
Journal Scan
Compared with oral anticoagulant (OAC)-experienced patients, OAC-naïve patients received the same benefit in decreased bleeding risk with asundexian vs. apixaban but they were also less likely to experience the increased risk of stroke or systemic...
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Dyslipidemia, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Lipid Metabolism, Novel Agents
Keywords: Factor XIa, Embolism, Anticoagulants, Stroke, Atrial Fibrillation